|
2021
|
Invention
|
Multiple antigenic peptide against coronavirus and immunostimulating composition containing the s... |
|
|
Invention
|
Multiple antigenic peptide against coronavirus, and immunostimulating composition containing same... |
|
2019
|
Invention
|
Anti-ige antibody specifically binding to membrane-bound ige antibody of ige antibody-producing b... |
|
2017
|
Invention
|
Immunity inducer.
This application relates to an useful drug for prevention or treatment of avia... |
|
|
Invention
|
Immunity inducer. The present application pertains to a medicinal agent which is useful for preve... |
|
|
Invention
|
Ebola virus vaccine.
This application provides: a multiple antigen peptide comprising a dendriti... |
|
|
Invention
|
Ebola virus vaccine. Provided are: a multi-antigenic peptide comprising a dendritic core and 4-8 ... |
|
2015
|
Invention
|
Multiplexed same type-antigenic peptide. The present invention provides a synthetic peptide capab... |
|
|
Invention
|
Multiplex alloantigenic peptide. The present invention provides a synthetic peptide whereby anti... |
|
|
Invention
|
Multiplexed same type-antigenic peptide. The present invention provides a synthetic peptide where... |
|
2014
|
Invention
|
Anti-dog ige monoclonal antibody, and light-chain variable region and heavy-chain variable region... |
|
2010
|
Invention
|
Method for detection of allergen-specific lymphocytes. Disclosed is a method for detecting allerg... |
|
2009
|
Invention
|
Method for quantification of antigen-specific canine or human ige. Disclosed is a convenient and ... |
